Wilder, Julius M <br/><br/>
Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Feb 2016 
 - 437-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.28334  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Black or African American<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--adverse effects<br/>Benzimidazoles--adverse effects<br/>Female<br/>Fluorenes--adverse effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Sofosbuvir<br/>Treatment Outcome<br/>Uridine Monophosphate--adverse effects<br/>Young Adult